Early research (Phase 1)Study completedNCT01658800
What this trial is testing
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Who this might be right for
Influenza
VaxInnate Corporation 275
Showing 20 of 0 results